Table 2.
HPV type | No | Overall prevalence,% |
Prevalence by age group,% |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
18-24 (n = 374) | 25-29 (n = 856) | 30-34 (n = 977) | 35-39 (n = 1035) | 40-44 (n = 813) | 45-49 (n = 781) | 50-54 (n = 447) | 55-59 (n = 383) | 60-65 (n = 270) | |||
Any HR types |
412 |
6.9 |
9.4 |
7.0 |
5.0 |
6.9 |
5.4 |
7.7 |
8.7 |
8.1 |
8.5 |
16 |
203 |
3.4 |
2.2 |
4.4 |
2.4 |
4.0 |
3.2 |
1.8 |
5.0 |
3.2 |
3.8 |
18 |
45 |
0.8 |
0.5 |
0.7 |
1.0 |
1.0 |
0.4 |
0.6 |
2.0 |
0 |
0 |
26 |
4 |
0.07 |
0 |
0.1 |
0 |
0 |
0 |
0.3 |
0.1 |
0 |
0 |
31 |
40 |
0.7 |
1.1 |
0.9 |
0 |
0.7 |
1.2 |
0.9 |
0 |
0.8 |
0.7 |
33 |
72 |
1.2 |
2.4 |
0.7 |
0.6 |
0.8 |
0.7 |
1.2 |
0 |
5.0 |
3.3 |
35 |
9 |
0.15 |
0 |
0.1 |
0.1 |
0.4 |
0.2 |
0.1 |
0 |
0 |
0 |
39 |
44 |
0.74 |
2.1 |
1.6 |
0.3 |
0.5 |
0.4 |
0.4 |
1.1 |
0.8 |
0 |
45 |
15 |
0.25 |
0.5 |
0 |
0.2 |
0 |
0.6 |
0.3 |
0 |
0.5 |
0.7 |
51 |
17 |
0.29 |
0.3 |
0.1 |
0.2 |
0.4 |
0.4 |
0.4 |
0.4 |
0.3 |
0 |
52 |
52 |
0.88 |
1.6 |
0.8 |
0.6 |
1.1 |
0.7 |
0.6 |
1.1 |
1.0 |
0.7 |
56 |
103 |
1.7 |
1.1 |
1.2 |
2.6 |
1.5 |
1.0 |
2.2 |
1.3 |
2.1 |
3.3 |
58 |
84 |
1.4 |
1.6 |
2.3 |
0.6 |
1.0 |
1.0 |
1.5 |
2.0 |
0.8 |
3.7 |
59 |
7 |
0.12 |
0.3 |
0 |
0.2 |
0.1 |
0 |
0 |
0.4 |
0 |
0.4 |
66 |
31 |
0.52 |
1.3 |
0.5 |
0.6 |
0.3 |
0.1 |
0.5 |
1.1 |
0.5 |
0.4 |
68 |
19 |
0.32 |
0 |
0.4 |
0.3 |
0.4 |
0.1 |
0.6 |
0.2 |
0.5 |
0 |
Single |
204 |
3.4 |
3.5 |
4.6 |
2.9 |
3.7 |
2.8 |
2.9 |
2.9 |
3.9 |
4.4 |
Multiple | 208 | 3.5 | 5.9 | 2.5 | 2.1 | 3.2 | 2.6 | 4.7 | 5.8 | 4.2 | 4.1 |
HPV: human papillomavirus, No.: number, HR: high-risk.
*The prevalence of an individual type or category included detection of this type or category in both single- and multiple-type infection.